Innovent Biologics Investor Relations Material
Latest events
Investor Update
Innovent Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Innovent Biologics Inc
Access all reports
Innovent Biologics Inc. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of biologic drugs, primarily targeting oncology, autoimmune, metabolic, and ophthalmology diseases. The company develops monoclonal antibodies and other biologic therapies aimed at addressing unmet medical needs, particularly within the Chinese market. The company is headquartered in Suzhou, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for Innovent Biologics Inc
Investor Update
Innovent Biologics Inc
Investor Update
Innovent Biologics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
1801
Country
🇭🇰 Hong Kong